Why do edibles not work for some people

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Edibles may not work for some people due to genetic variations in liver enzymes, particularly CYP2C9, which metabolizes THC. First-pass metabolism in the liver converts THC to 11-hydroxy-THC, but inefficient conversion can reduce effects. Individual differences in metabolism, tolerance, and gastrointestinal factors also play roles, with studies showing up to 20-30% of users report inconsistent effects from edibles.

Key Facts

Genetic variations in CYP2C9 enzyme affect THC metabolism efficiency
First-pass liver metabolism converts THC to 11-hydroxy-THC
Up to 20-30% of users report inconsistent effects from edibles
Gastrointestinal factors like food intake can delay absorption by 2-4 hours
Tolerance buildup requires higher doses over time

Overview

Edibles, or cannabis-infused food products, have been used medicinally and recreationally for centuries, with documented use dating back to ancient China around 2700 BCE. Modern edibles gained popularity in the 1960s counterculture movement, particularly with "Alice B. Toklas brownies" in the United States. The legal cannabis market has expanded significantly since Colorado's legalization in 2014, with edibles accounting for approximately 15-20% of total cannabis sales in legal markets by 2023. Unlike smoking, which delivers cannabinoids directly to the bloodstream through the lungs, edibles must pass through the digestive system, creating variability in onset time (30 minutes to 2 hours) and duration (4-12 hours). This metabolic pathway introduces multiple points where individual differences can affect efficacy, making edibles notoriously unpredictable compared to other consumption methods.

How It Works

When consumed, edibles undergo first-pass metabolism in the liver, where enzymes like CYP2C9 convert delta-9-THC into 11-hydroxy-THC, a more potent metabolite that crosses the blood-brain barrier more efficiently. This process typically takes 30-90 minutes, but can be delayed by factors like food intake, which slows gastric emptying. Genetic polymorphisms in CYP2C9 affect conversion efficiency, with some individuals producing insufficient enzymes for effective metabolism. Additionally, gastrointestinal issues like irritable bowel syndrome or variations in gut microbiome composition can impair absorption. Tolerance also develops through downregulation of CB1 receptors in the endocannabinoid system, requiring progressively higher doses. The delayed onset often leads users to consume more prematurely, potentially causing overconsumption and adverse effects.

Why It Matters

Understanding why edibles fail for some users is crucial for medical applications, where consistent dosing is essential for conditions like chronic pain, epilepsy, or chemotherapy-induced nausea. Inconsistent effects can lead to medication non-adherence or accidental overconsumption, contributing to approximately 10-15% of cannabis-related emergency department visits. For recreational users, unpredictable experiences may discourage responsible use or lead to negative outcomes. Research into genetic testing for cannabis metabolism could personalize dosing, improving safety and efficacy. As legal markets expand globally, addressing these variability issues through standardized manufacturing, clear labeling, and consumer education becomes increasingly important for public health and regulatory compliance.